摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Methyl 2-methoxy-2,3-dihydro-1-benzofuran-3-carboxylate

中文名称
——
中文别名
——
英文名称
Methyl 2-methoxy-2,3-dihydro-1-benzofuran-3-carboxylate
英文别名
——
Methyl 2-methoxy-2,3-dihydro-1-benzofuran-3-carboxylate化学式
CAS
——
化学式
C11H12O4
mdl
——
分子量
208.21
InChiKey
UWOUHGRXXIDLKN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    44.8
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • Methods for Preparing Azoxystrobin and Intermediate Thereof
    申请人:NUTRICHEM COMPANY LIMITED
    公开号:US20160200687A1
    公开(公告)日:2016-07-14
    The present invention discloses a method for preparing azoxystrobin intermediates represented by formulae (1) and (2), comprising: controlling a compound represented by formula (3) to contact with sodium methoxide and 4,6-dichloropyrimidine, to obtain a mixture of intermediates represented by formulae (1) and (2), in the existence of a catalyst, the catalyst is an azabicyclic compound or its salt. The present invention further discloses a method for preparing azoxystrobin, comprising: controlling the intermediate represented by formula (2) provided in the present invention to react with 2-cyanophenol or its salt under the catalytic action of an azabicyclic compound or its salt, to obtain an azoxystrobin compound represented by formula (4). The method provided in the present invention has advantages including high transformation ratio, high product purity, easy and convenient operation, and environmental friendliness.
    本发明揭示了一种制备由式(1)和(2)表示的阿托霉唑中间体的方法,包括:控制由式(3)表示的化合物与甲和4,6-二氯嘧啶接触,以在存在催化剂的情况下获得由式(1)和(2)表示的中间体的混合物,其中催化剂吡啶环化合物或其盐。本发明还揭示了一种制备阿托霉唑的方法,包括:控制本发明提供的由式(2)表示的中间体,在吡啶环化合物或其盐的催化作用下与2-苯酚反应,以获得由式(4)表示的阿托霉唑化合物。本发明提供的方法具有高转化率、高产品纯度、操作简便方便和环保友好等优点。
  • METHODS FOR PREPARING AZOXYSTROBIN AND INTERMEDIATE THEREOF
    申请人:Nutrichem Company Limited
    公开号:EP3042896A1
    公开(公告)日:2016-07-13
    The present invention discloses a method for preparing azoxystrobin intermediates represented by formulae (1) and (2), comprising: controlling a compound represented by formula (3) to contact with sodium methoxide and 4,6-dichloropyrimidine, to obtain a mixture of intermediates represented by formulae (1) and (2), in the existence of a catalyst, the catalyst is an azabicyclic compound or its salt. The present invention further discloses a method for preparing azoxystrobin, comprising: controlling the intermediate represented by formula (2) provided in the present invention to react with 2-cyanophenol or its salt under the catalytic action of an azabicyclic compound or its salt, to obtain an azoxystrobin compound represented by formula (4). The method provided in the present invention has advantages including high transformation ratio, high product purity, easy and convenient operation, and environmental friendliness.
    本发明公开了一种制备式(1)和(2)代表的唑菌酯中间体的方法,包括:控制式(3)代表的化合物与甲醇钠和4,6-二氯嘧啶接触,得到式(1)和(2)代表的中间体混合物,在存在催化剂的情况下,催化剂杂环化合物或其盐。本发明进一步公开了一种制备唑啉草酯的方法,包括:控制本发明提供的式(2)代表的中间体杂环化合物或其盐的催化作用下与2-苯酚或其盐反应,得到式(4)代表的唑啉草酯化合物。本发明提供的方法具有转化率高、产品纯度高、操作简单方便、环保等优点。
  • Method for preparing azoxystrobin and its intermediates
    申请人:Nutrichem Company Limited
    公开号:US10253001B2
    公开(公告)日:2019-04-09
    The present invention discloses a method for preparing azoxystrobin intermediates represented by formulae (1) and (2), comprising: controlling a compound represented by formula (3) to contact with sodium methoxide and 4,6-dichloropyrimidine, to obtain a mixture of intermediates represented by formulae (1) and (2), in the existence of a catalyst, the catalyst is an azabicyclic compound or its salt. The present invention further discloses a method for preparing azoxystrobin, comprising: controlling the intermediate represented by formula (2) provided in the present invention to react with 2-cyanophenol or its salt under the catalytic action of an azabicyclic compound or its salt, to obtain an azoxystrobin compound represented by formula (4). The method provided in the present invention has advantages including high transformation ratio, high product purity, easy and convenient operation, and environmental friendliness.
    本发明公开了一种制备式(1)和(2)代表的唑菌酯中间体的方法,包括:控制式(3)代表的化合物与甲醇钠和4,6-二氯嘧啶接触,得到式(1)和(2)代表的中间体混合物,在存在催化剂的情况下,催化剂杂环化合物或其盐。本发明进一步公开了一种制备唑啉草酯的方法,包括:控制本发明提供的式(2)代表的中间体杂环化合物或其盐的催化作用下与2-苯酚或其盐反应,得到式(4)代表的唑啉草酯化合物。本发明提供的方法具有转化率高、产品纯度高、操作简单方便、环保等优点。
  • [EN] METHODS FOR PREPARING AZOXYSTROBIN AND INTERMEDIATE THEREOF<br/>[FR] PROCÉDÉ DE PRÉPARATION D'AZOXYSTROBINE ET DE SON INTERMÉDIAIRE
    申请人:NUTRICHEM COMPANY LTD
    公开号:WO2015032192A1
    公开(公告)日:2015-03-12
    本发明公开了一种制备式(1)和式(2)所示嘧菌酯中间体的方法,该方法包括:在催化剂存在下,将式(3)所示化合物与甲醇钠及4,6-二氯嘧啶接触,得到式(1)和式(2)所示中间体的混合物,所述催化剂杂二环化合物或其盐。本发明还公开了一种制备嘧菌酯的方法,该方法包括将本发明提供的式(2)所示中间体与2-苯酚或其盐在杂二环化合物或其盐的催化下反应,得到式(4)所示嘧菌酯化合物。本发明提供的方法具有转化率高、产品纯度高、操作简便及对环境友好的突出优点。
  • METHOD FOR PREPARING AZOXYSTROBIN AND ITS INTERMEDIATES
    申请人:Nutrichem Company Limited
    公开号:US20180141918A1
    公开(公告)日:2018-05-24
    The present invention discloses a method for preparing azoxystrobin intermediates represented by formulae (1) and (2), comprising: controlling a compound represented by formula (3) to contact with sodium methoxide and 4,6-dichloropyrimidine, to obtain a mixture of intermediates represented by formulae (1) and (2), in the existence of a catalyst, the catalyst is an azabicyclic compound or its salt. The present invention further discloses a method for preparing azoxystrobin, comprising: controlling the intermediate represented by formula (2) provided in the present invention to react with 2-cyanophenol or its salt under the catalytic action of an azabicyclic compound or its salt, to obtain an azoxystrobin compound represented by formula (4). The method provided in the present invention has advantages including high transformation ratio, high product purity, easy and convenient operation, and environmental friendliness.
查看更多

同类化合物

黄曲霉毒素 D1 顺式-3alpha,8alpha-二氢-4,6-二甲氧基-呋喃并[2,3-b]苯并呋喃 阿莫拉酮 苯甲醇,-α--甲基-4-(2-甲基丙基)-,乙酸酯(9CI) 苯并呋喃,7-氯-2,3-二氢-2,2-二甲基- 苯并呋喃,4-氯-2,3-二氢- 苯并呋喃,2,3-二氢-3-[(苯基硫代)甲基]- 苯并呋喃,2,3-二氢-2-(苯基亚甲基)-,(E)- 苯并二氢呋喃-4-甲醛 苯并二氢呋喃-4-甲酸 苯并二氢呋喃-2-羧酸 胆甾-8-烯-3,15-二醇,(3b,5a,15a)-(9CI) 聚苯硫醚 维拉佐酮杂质24 盐酸依法洛沙 甲基苄基(2,3-二氢苯并呋喃-3-基)氨基甲酸酯 甲基氨基甲酸4-氯-2,3-二氢-2,2-二甲基苯并呋喃-7-基酯 甲基5-氨基-2,3-二氢-1-苯并呋喃-2-羧酸酯 甲基2-乙基-6-羟基-2,3-二氢-1-苯并呋喃-2-羧酸酯 甲基(2S)-2-乙基-2,3-二氢-1-苯并呋喃-2-羧酸酯 环丙基甲胺 灭草呋喃 氘代克百威(呋喃丹) 普芦卡必利杂质H 抗氧剂136 多特林中间体 呋草黄 呋罗芬酸 呋喃酚 十一碳烯 克百威 依法克生 他司美琼 人参宁 二苯基异壬基膦酸酯 二硫代双(甲基氨基甲酸)双(2,3-二氢-2,2-二甲基-7-苯并呋喃)酯 二[2,3-二氢-2,2-二甲基-7-苯并呋喃重氮鎓]硫酸盐 二-2,3-二氢-1-苯并呋喃-5-基乙酸 乙基3-(7-溴-2,3-二氢-1-苯并呋喃-5-基)丙酸酯 丙硫克百威 丁硫克百威 [2H4]-2,3-二氢-5-苯并呋喃乙醇 [2H18]-丁硫克百威 [2-[2-氧代-5-(2,4,4-三甲基戊烷-2-基)-3H-1-苯并呋喃-3-基]-4-(2,4,4-三甲基戊烷-2-基)苯基]乙酸酯 [2,3-二氢-1-苯并呋喃-3-基(苯基)甲基]-二甲基-苯基硅烷 [2,2-二甲基-7-(甲基氨基甲酰氧基)-3H-1-苯并呋喃-3-基](Z)-2-甲基丁-2-烯酸酯 N-甲基氨基甲酸2,3-二氢苯并呋喃-7-基酯 N-甲基氨基甲酸2,3-二氢-2,2,4-三甲基苯并呋喃-7-基酯 N-甲基-[(2,3-二氢苯并[b]呋喃-7-基)甲基]胺 N-甲基(2,3-二氢苯并呋喃-2-基)甲胺盐酸盐